TECHNICAL AND PATENT PERSPECTIVE ON FILM FORMING TOPICAL SPRAYS
DOI:
https://doi.org/10.22159/ijpps.2024v16i12.52109Keywords:
Anti-fungal agents, Film-forming agents, Film-forming systems, Patented Formulations, Sustained drug release, Topical drug delivery system, Transdermal spraysAbstract
Film-forming systems were a viable option for topical and transdermal medication administration in the present study. Medication administered via the skin serves two purposes: topical treatment of skin disorders and transdermal drug absorption into the circulation. Apart from the ease of self-administration, the topical route provides a broad and diverse surface and functions as a substitute for oral and hypodermic injection drug delivery routes. Existing dosage forms, such as creams, patches, and ointments, have several drawbacks. In addition to being unsightly, patches can be painful to put on curved surfaces, create discomfort while peeling off, and most often cause skin irritation because of their occlusive qualities, which block sweat ducts and prevent perspiration from evaporating from the skin surface. This review encompasses the mechanism of polymers, such as ethyl cellulose and Eudragit types, plasticizers, and penetration enhancers utilized in film formation. Overall, polymeric film-forming sprays exhibit substantial potential for the convenient administration of antibiotics and antiseptics to treat bacterial, fungal, and viral skin infections. The application of topical medication is thought to result in both local and systemic effects. The physicochemical characteristics of the medication and patient adherence determine how well the topical treatment works. Poor permeability and poor adherence to the skin are some of the disadvantages of conventional pharmaceutical formulations for topical and dermatological administration. The development of medication delivery technologies intended for topical administration to the skin includes the use of topical film-forming systems.
Downloads
References
Boer M, Duchnik E, Maleszka R, Marchlewicz M. Structural and biophysical characteristics of human skin in maintaining proper epidermal barrier functions. Postepy Dermatol Alergol. 2016;33(1):1-5. doi: 10.5114/pdia.2015.48037, PMID 26985171.
Jenkins G, Tortora GJ. Anatomy and physiology. John Wiley & Sons; 2016 May 3.
KI V, Rotstein C. Bacterial skin and soft tissue infections in adults: a review of their epidemiology pathogenesis diagnosis treatment and site of care. Can J Infect dis Med Microbiol. 2008 Mar;19(2):173-84. doi: 10.1155/2008/846453, PMID 19352449.
Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39(3):309-17. doi: 10.1086/421946, PMID 15306996.
Pfaller MA, Diekema DJ, Turnidge JD, Castanheira M, Jones RN. Twenty years of the sentry antifungal surveillance program: results for candida species from 1997-2016. Open Forum Infect Dis. 2019;6 Suppl 1:S79-94. doi: 10.1093/ofid/ofy358, PMID 30895218.
Gonzalez LM, Ruder WC, Mitchell AP, Messner WC, Leduc PR. Sudden motility reversal indicates sensing of magnetic field gradients in magneto spirillum magneticum AMB-1 strain. ISME J. 2015;9(6):1399-409. doi: 10.1038/ismej.2014.224, PMID 25478682.
Vishwakarma G, Singh Panwar A. Emulgel emergent systems: at a glance for topical drug delivery. Asian J Pharm Clin Res. 2022;15(3):8-14. doi: 10.22159/ajpcr.2022.v15i3.43876.
Kathe K, Kathpalia H. Film forming systems for topical and transdermal drug delivery. In: Asian Journal of Pharmaceutical Research; 2016. p. 4-5.
Abd UK. Film forming spray for topical drug delivery article in drug design development and therapy; 2020. p. 4-5.
Bakhrushina EO, Shumkova MM, Sergienko FS, Novozhilova EV, Demina NB. Spray film forming systems as promising topical in situ systems: a review. Saudi Pharm J. 2023 Jan;31(1):154-69. doi: 10.1016/j.jsps.2022.11.014, PMID 36685308, PMCID PMC9845128.
Mori NM, Patel P, Sheth NR, Rathod LV, Ashara KC. Fabrication and characterization of film-forming voriconazole transdermal spray for the treatment of fungal infection. Bull Fac Pharm Cairo Univ. 2017;55(1):41-51. doi: 10.1016/j.bfopcu.2017.01.001.
Manam M, Rao M Prasad. Top spray formulation glycopyrrolate US 20190099344 A1 Apr; 2019.
Chavers TH. Flurandrenolide film formation. US4210633. A Jul; 1980.
Tillmann K, Jonatham K. An aqueous antimicrobial film forming composition for teat treatment by spray application. WO2016/206729 A1, Dec; 2016.
Amar L. Topical spray. Vol. WO00 (45795, August); 2000.
Fahim AU. Barrier film forming composition and methods of use. US 8,778,369 B2, Jul; 2014.
Mc Entire Edward Enns. Water dispersible films for delivery of active agents to the epidermis. US2007/0258935 A1 Nov; 2007.
Saafir A, Hajduk D. Water resistant film forming composition incorporating hydrophilic activities. US2007/0238807 A1, Oct; 2007.
Paul A, Sarkar A. Topical film delivery system. US 20170049789; 2017.
Kottayeil S, Kumar A. Topical film-forming spray. US2022/0133642 A1; 2022.
Edith M. Anti-acne topical films. US 20140271931; 2014.
George K, Kumar A. Topical film-forming spray. EP 3. 2021;B1:80-380.
Laurent P. Film forming composition for spraying on the skin. US 6,325,990 B1; 2001.
Raut P, Malhotra G. Topical sprays comprising a film-forming composition. EP 1. 2003;B1:661:150.
Hardy. C Film forming composition. US 9,782,514 B2; 2017.
Suzuki H. Protective film-forming spray for skin surface. US 2021/0330509 A1; 2021.
Halloran D, Yelena Z. Film forming composition for topical use and delivery of active ingredients. US 6,797,262 B2, Sep; 2004.
Israel D. John kuleza therapeutic film forming composition and treatment system therefor US 20040071760, Vol A1 (Apr); 2004.
Luppo Edens BN. Topical application of enzymes using a peelable film. US 20010006675; 2001.
Celestino R. Topical composition for covering a skin lesion. EP 1. 2002;A1:352.
Thomas X. Topical compositions WO 2012/09575 A2; 2022.
John M, Neville J. Improvement in therapeutic composition for topical application 1213295; 1970.
Das D, Vizzotli E. Topical analgesic composition US2020/0345696. Vol. A1; 2020.
Claire B. Topical film forming composition and use thereof for treating Mycosis. US2014/0128468 A1; 2014.
Kendel N. Film forming liquid composition. EP 1. 2003;A1:137-321.
Amar M. Topical pharmaceutical composition WO 2009/101412. Vol. A1 (Aug); 2009.
Karen C. Non-leaching surface-active film compositions for microbial adhesion prevention. 2007;A1(Jul):CA2636975.
Lozinsky E. Composition for the treatment of epistaxis. WO2016/178053 A1; Nov 2016.
Film-forming solutions of copolymers of N-vinyl pyrrolidone and N-vinyl ester. 1960;820:970.
Troyano N. In situ film forming composition WO 2022/234081. Vol. A1; 2022.
Dandiker Y, Panchal M. Testosterone transdermal spray with film. WO2019/140087 A1 Jul; 2019.
Russell M, Jay M. Ph-sensitive mucoadhesive film-forming gels and wax film composites suitable for topical and mucosal delivery of molecules; 2002;WO02(051382):A2.
Sapkal P, Davel L. Pharmaceutical microemulsion immobilized in a thin polymer matrix and method of making them. WO2015/107544 A2 Jul; 2015.
Inorie E, Jmaes. Film forming composition for topical use. WO86/07255; Dec 1986.
Barry Brown A. Topical film forming monophasic formulation. NZ567022 A; 2011.
David K. Water resistant film forming antimicrobial skin preparation. 2001;B1(May):US6228354.
Wilson L. Sprayable film forming composition for improving the performance of topical preparation. 2021;B1:US11129788.
Kim B. Agent for forming film on skin US2021/0361556. Vol. A1; 2021.
Cho CW, Kim DB, Shin SC. Development of bioadhesive transdermal bupivacaine gels for enhanced local anesthetic action. Iran J Pharm Res. 2012;11(2):423-31. PMID 24250466, PMCID PMC3832163.
Paradkar M, Thakkar V, Soni T, Gandhi T, Gohel M. Formulation and evaluation of clotrimazole transdermal spray. Drug Dev Ind Pharm. 2015;41(10):1718-25. doi: 10.3109/03639045.2014.1002408, PMID 25579237.
Etodolac topical spray films development characterization and in vitro evaluation. Int J Pharmacol Res. 2020.
Dhimmar B, Pokale R, Rahamathulla M, Hani U, Alshahrani MY, Alshehri SM. Newfangled topical film forming solution for facilitated antifungal therapy: design development characterization and in vitro evaluation. Polymers. 2023;15(4):1. doi: 10.3390/polym15041003, PMID 36850286.
Desai MN, Godbole AM, Somnache SN, Gajare PS, Pednekar AS, Manerikar S. Design development and characterization of film forming spray as novel antifungal topical formulation for superficial fungal infections. Ind J Pharm Edu Res. 2022;56(4s):s651-8. doi: 10.5530/ijper.56.4s.211.
Sritharadol R, Nakpheng T, Wan Sia Heng P, Srichana T. Development of a topical mupirocin spray for antibacterial and wound healing applications. Drug Dev Ind Pharm. 2017;43(10):1715-28. doi: 10.1080/03639045.2017.1339077, PMID 28581830.
Bakshi A, Bajaj AN, Malhotra G, Madan M, Amrutiya N. A novel metered dose transdermal spray formulation for oxybutynin. Indian J Pharm Sci. 2008;70(6):733-9. doi: 10.4103/0250-474X.49094, PMID 21369433.
Chamsai B, Soodvilai S, Opanasopit P, Samprasit W. Topical film forming chlorhexidine gluconate sprays for antiseptic application. Pharmaceutics. 2022;14(6):1124. doi: 10.3390/pharmaceutics14061124, PMID 35745696.
Abdullah N, Patil AB. Designing of novel topical in situ polymeric film forming solution spray formulation of antifungal agent: in vitro activity and in vivo characterization. Int J App Pharm. 2022:14(1):169-84. doi: 10.22159/ijap.2022v14i1.43581.
Gohel MC, Nagori SA. Fabrication of modified transport fluconazole transdermal spray containing ethyl cellulose and Eudragit RS100 as film formers. AAPS Pharm Sci Tech. 2009;10(2):684-91. doi: 10.1208/s12249-009-9256-8, PMID 19462250.
Ammar HO, Ghorab M, Mahmoud AA, Makram TS, Ghoneim AM. Rapid pain relief using transdermal film forming a polymeric solution of ketorolac. Pharm Dev Technol. 2013 Sep-Oct;18(5):1005-16. doi: 10.3109/10837450.2011.627867, PMID 22191998.
Vasia GL, T, Chavan VP, Chanaky M, JM, H, Murthy. Development and characterization of novel film-forming polymeric solution of silver sulfadiazine for burn wound care. Pharm Sci Formulation. 2020. Available from: Available from: https://ssrn.com/abstract=3529068. [Last accessed on 31 Jan 2020].
Ranade SC, Bajaj AN, Londhe VY, Babul N, Kao D. Fabrication of topical metered dose film forming sprays for pain management. Eur J Pharm Sci. 2017;100:132-41. doi: 10.1016/j.ejps.2017.01.004, PMID 28069427.
Rajab Nawal A. Preparation and evaluation of ketoprofen as dermal spray film. Kerbala Journal of Pharmaceutical Sciences; 2013 Dec.
Kathe K, Kathpalia H. Film forming systems for topical and transdermal drug delivery. Asian Journal of Pharmaceutical Research; 2016. p. 4-5.
Karagianni A, Peltonen L. Production of itraconazole nanocrystal based polymeric film formulations for immediate drug release. Pharmaceutics. 2020 Oct 13;12(10):33065968. doi: 10.3390/pharmaceutics12100960, PMID 33065968, PMCID PMC7600483.
Basu B, Garala KC, Tyagi M, Prabhushankar GL, Babu PR. Formulation and in vitro evaluation of periodontal films containing metronidazole. Res J Pharm Dosage Forms Technol. 2009;1:240-3.
LU W, Luo H, Zhu Z, WU Y, Luo J, Wang H. Preparation and the biopharmaceutical evaluation for the metered dose transdermal spray of dexketoprofen. J Drug Deliv. 2014;2014:697434. doi: 10.1155/2014/697434, PMID 24660066.
Kittaneh M, Qurt M, Malkieh N, Naseef HA, Muqedi RH. Preparation and evaluation of vitamin D3 supplementation as transdermal film-forming solution. Pharmaceutics. 2022;15(1):VD3. doi: 10.3390/pharmaceutics15010039, PMID 36678668.
Published
How to Cite
Issue
Section
Copyright (c) 2024 M. H. DEHGHAN, SailiSAILI P. RAJPUT
This work is licensed under a Creative Commons Attribution 4.0 International License.